Association of 5-lipoxygenase activating protein gene polymorphism and stroke: A study from north east of Iran

Marjan Erfani, A. Sadr-Nabavi, Reza Jafarzadeh-Esfehani, M. Shariati, Leila Ghanbari-Garekani, Samaneh Vojdani-Chahchaheh, P. Sasannejad
{"title":"Association of 5-lipoxygenase activating protein gene polymorphism and stroke: A study from north east of Iran","authors":"Marjan Erfani, A. Sadr-Nabavi, Reza Jafarzadeh-Esfehani, M. Shariati, Leila Ghanbari-Garekani, Samaneh Vojdani-Chahchaheh, P. Sasannejad","doi":"10.18502/IJNL.V18I3.1634","DOIUrl":null,"url":null,"abstract":"Background: Stroke is a multifactorial disorder and a major cause of morbidity and mortality around the world. There are growing numbers of candidate gene pathways which are thought to be associated with stroke. Genes involved in lipid metabolism are important issues in stroke studies. Studying different polymorphisms in these genes are becoming an interest for researchers. 5-lipoxygenase activating protein (ALOX5AP) is one of these genes. Different studies have provided different relations between ALOX5AP promoter polymorphism (rs17222919) and stroke. In the present study, we have evaluated this gene polymorphism in a population in north east of Iran. Methods: This case-control study took place in Ghaem Hospital, Mashhad, Iran. Patients with computed tomography (CT) or magnetic resonance imaging (MRI) confirmation for ischemic stroke were enrolled in this study and considered as case group. Healthy persons without ischemic stroke were control group. During 1-year period of this study, ALOX5AP gene polymorphism in 200 healthy patients (control group) as well as 228 patients with stroke (case group) was evaluated by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Results: All of 428 persons (228 cases and 200 healthy controls) enrolled in this study. The genotype and allele frequency was significantly different between both groups (P = 0.001 and P = 0.003, respectively). A total number of 54 patients had G allele in case group in contrast to 27 ones in control group. Also, 174 patients in case group had T allele and 173 persons had this allele in control group. In compression of TT genotype, the risk of developing stroke in GG and TG genotypes increased by 3.998 and 1.643, respectively. Also the risk of ischemic stroke with G allele would increase by 2.128. Conclusion: According to our results, ALOX5AP promoter polymorphism (rs17222919) is related to increased ischemic stroke in Iranian population.","PeriodicalId":45759,"journal":{"name":"Iranian Journal of Neurology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/IJNL.V18I3.1634","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Stroke is a multifactorial disorder and a major cause of morbidity and mortality around the world. There are growing numbers of candidate gene pathways which are thought to be associated with stroke. Genes involved in lipid metabolism are important issues in stroke studies. Studying different polymorphisms in these genes are becoming an interest for researchers. 5-lipoxygenase activating protein (ALOX5AP) is one of these genes. Different studies have provided different relations between ALOX5AP promoter polymorphism (rs17222919) and stroke. In the present study, we have evaluated this gene polymorphism in a population in north east of Iran. Methods: This case-control study took place in Ghaem Hospital, Mashhad, Iran. Patients with computed tomography (CT) or magnetic resonance imaging (MRI) confirmation for ischemic stroke were enrolled in this study and considered as case group. Healthy persons without ischemic stroke were control group. During 1-year period of this study, ALOX5AP gene polymorphism in 200 healthy patients (control group) as well as 228 patients with stroke (case group) was evaluated by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Results: All of 428 persons (228 cases and 200 healthy controls) enrolled in this study. The genotype and allele frequency was significantly different between both groups (P = 0.001 and P = 0.003, respectively). A total number of 54 patients had G allele in case group in contrast to 27 ones in control group. Also, 174 patients in case group had T allele and 173 persons had this allele in control group. In compression of TT genotype, the risk of developing stroke in GG and TG genotypes increased by 3.998 and 1.643, respectively. Also the risk of ischemic stroke with G allele would increase by 2.128. Conclusion: According to our results, ALOX5AP promoter polymorphism (rs17222919) is related to increased ischemic stroke in Iranian population.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
伊朗东北部5-脂氧合酶激活蛋白基因多态性与脑卒中的相关性研究
背景:脑卒中是一种多因素疾病,是世界各地发病率和死亡率的主要原因。越来越多的候选基因通路被认为与中风有关。参与脂质代谢的基因是中风研究中的重要问题。研究这些基因的不同多态性正成为研究人员的兴趣所在。5-脂氧合酶激活蛋白(ALOX5AP)就是其中的一个基因。不同的研究提供了ALOX5AP启动子多态性(rs17222919)与中风之间的不同关系。在本研究中,我们在伊朗东北部的一个人群中评估了这种基因多态性。方法:本病例对照研究在伊朗马什哈德的盖姆医院进行。计算机断层扫描(CT)或磁共振成像(MRI)证实缺血性中风的患者被纳入本研究,并被视为病例组。对照组为无缺血性脑卒中的健康人。在本研究的1年期间,采用聚合酶链式反应-限制性片段长度多态性(PCR-RFLP)对200名健康患者(对照组)和228名中风患者(病例组)的ALOX5AP基因多态性进行了评估。结果:428名患者(228例,200名健康对照)全部纳入本研究。基因型和等位基因频率在两组之间有显著差异(分别为P=0.001和P=0.003)。病例组共有54例患者具有G等位基因,而对照组为27例。病例组174例患者具有T等位基因,对照组173例患者具有该等位基因。在TT基因型的压缩中,GG和TG基因型发生中风的风险分别增加了3.998和1.643。此外,G等位基因的缺血性中风风险将增加2.128。结论:根据我们的研究结果,ALOX5AP启动子多态性(rs17222919)与伊朗人群缺血性脑卒中的增加有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Iranian Journal of Neurology
Iranian Journal of Neurology CLINICAL NEUROLOGY-
自引率
0.00%
发文量
0
期刊最新文献
Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica. Effectiveness and side effects of dimethyl fumarate in multiple sclerosis after 12 months of follow up: An Iranian clinical trial. Thrombolytic treatment in stroke mimic, inevitable but fortunately safe: An observational study from Iran. Fitness to drive in seizure and epilepsy: A protocol for Iranian clinicians. A survey from Turkey and Iran on comparison of risk factors and etiology in ischemic stroke.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1